secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001193125-26-127785
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 2.04, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics files for winding up in Ireland; appoints provisional liquidators; CEO/CFO resign
--------------------------------------------------------------------------------

- Filed winding-up petition in Irish High Court; joint provisional liquidators appointed (Damien Murran, Jennifer McMahon of Teneo).
- CEO Corey Fishman and CFO Judith Matthews resigned effective immediately after petition filing.
- Filing triggered default under Royalty-Linked Notes; default interest rate set at prime plus 3%.
- Company cites limited cash, inability to raise capital, failed strategic alternatives, and modest ORLYNVAH sales as reasons.
- Nasdaq trading suspension expected March 27; shareholders likely to experience complete loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526127785/0001193125-26-127785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312526127785/itrm-20260327.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-127785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer